| |
| |
|
| Insider
Information: |
Quimi Daphne |
| Relationship: |
|
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
403,532 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,228,425 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
403,532 |
|
|
| Total
Value |
$4,228,425 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2023-01-18 |
398,532 |
2014-04-10 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-05-15 |
5,000 |
2024-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-07-01 |
4 |
OE |
$13.98 |
$36,350 |
D/D |
2,600 |
10,788 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Vice President Finance |
• – – |
2015-10-01 |
4 |
OE |
$13.13 |
$147,761 |
D/D |
11,250 |
16,938 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2016-11-09 |
4 |
OE |
$8.00 |
$22,864 |
D/D |
2,858 |
27,047 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2017-10-12 |
4 |
OE |
$14.25 |
$99,740 |
D/D |
7,000 |
61,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-02 |
4 |
OE |
$14.72 |
$117,723 |
D/D |
8,000 |
62,676 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-03-01 |
4 |
OE |
$4.16 |
$33,900 |
D/D |
8,149 |
72,481 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-03-09 |
4 |
OE |
$5.96 |
$52,150 |
D/D |
8,750 |
73,082 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-09 |
4 |
OE |
$2.52 |
$30,007 |
D/D |
11,022 |
177,991 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-07-01 |
4 |
OE |
$2.45 |
$52,054 |
D/D |
19,872 |
214,051 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-10-01 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
212,179 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-10-02 |
4 |
OE |
$2.45 |
$26,950 |
D/D |
11,000 |
218,179 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
OE |
$2.45 |
$99,222 |
D/D |
30,321 |
248,500 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-21 |
4 |
OE |
$2.94 |
$14,700 |
D/D |
5,000 |
249,344 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-03-05 |
4 |
OE |
$2.94 |
$48,886 |
D/D |
16,628 |
275,998 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
VP Finance and Controller |
• – – |
2015-05-08 |
4 |
D |
$10.80 |
$100,570 |
D/D |
(9,312) |
15,688 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
SVP, Finance |
• – – |
2018-01-03 |
4 |
D |
$15.67 |
$46,274 |
D/D |
(2,953) |
64,332 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-01-03 |
4 |
D |
$10.33 |
$39,771 |
D/D |
(3,850) |
117,953 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-06-17 |
4 |
D |
$11.35 |
$11,872 |
D/D |
(1,046) |
129,254 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-12-31 |
4 |
D |
$9.74 |
$65,599 |
D/D |
(6,735) |
122,519 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-02 |
4 |
D |
$9.55 |
$67,929 |
D/D |
(7,113) |
187,274 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-03 |
4 |
D |
$9.18 |
$48,700 |
D/D |
(5,305) |
181,969 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-01-10 |
4 |
D |
$9.46 |
$114,135 |
D/D |
(12,065) |
190,422 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-06-15 |
4 |
D |
$11.14 |
$11,652 |
D/D |
(1,046) |
194,179 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
D |
$23.86 |
$99,162 |
D/D |
(4,156) |
244,344 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
